Immunogenicity and Efficacy of Live-Attenuated <i>Salmonella</i> Typhimurium Vaccine Candidate CVD 1926 in a Rhesus Macaque Model of Gastroenteritis
Ellen E. Higginson(University of Maryland, Baltimore), Sharon M. Tennant(University of Maryland, Baltimore), Myron M. Levine(University of Maryland, Baltimore), Louis J. DeTolla(University of Maryland, Baltimore), Franklin R. Toapanta(University of Maryland, Baltimore), Jasnehta Permala-Booth(University of Maryland, Baltimore), Jennifer Jones(University of Maryland, Baltimore), Marcela F. Pasetti(University of Maryland Global Campus), Aruna Panda(University of Maryland, Baltimore), Marcelo B. Sztein(University of Maryland, Baltimore), Sunil Kumar Sen(University of Maryland, Baltimore), Matthew C Terzi(University of Maryland, Baltimore)
Cited by 13
Related Papers
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|Nature|1987|503
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls
|Infection and Immunity|2004|447
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
|Nature Reviews Microbiology|2007|372